Craft

Avedro

Revenue

$27.7 M

FY, 2018

Avedro Summary

Company Summary

Overview
Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals. Its products include Photrexa Viscous, Photrexa, and the KXL system, which are used for corneal cross-linking for patients suffering from progressive keratoconus and corneal ectasia.
Type
Subsidiary
Status
Active
Founded
2002
HQ
Waltham, MA, US | view all locations
Website
http://avedro.com/
Cybersecurity rating
Sectors

Key People

  • Tim Homer

    Tim Homer, VP, Health Policy & Market Policy

Operating MetricsView all

Distributors

42

FY, 2018

Phase III Patients Enrolled

384

FY, 2018

Trademarks Pending

19

Mar, 2019

LocationsView all

1 location detected

  • Waltham, MA HQ

    United States

    201 Jones Rd

Avedro Financials

Summary Financials

Revenue (Q3, 2019)
$11.0M
Gross profit (Q3, 2019)
$8.6M
Net income (Q3, 2019)
($9.1M)
Cash (Q3, 2019)
$52.1M
EBIT (Q3, 2019)
($8.1M)

Footer menu